Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

LON/0IFK stock hub

LON/0IFK has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0IFKis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

223.5M

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0IFK

In the news

Latest news · LON/0IFK

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROE-326.1

P25 -54.2P50 2.1P75 13.7

ROIC-96.6

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0IFK market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

171

Groups with data

Currency

USD

Showing 171 of 171 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	87
Employees Change	-19%
Employees Change Percent	-7.17
Enterprise value	$145.4M
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical - Pharmaceuticals
Isin	US28106W1036
Last refreshed	2026-05-10
Market cap	$223.5M
Price	$3.19
Price currency	USD
Rev Per Employee	336,809.22x
Sector	Healthcare
Sic	2836
Symbol	lon/0IFK
Website	https://www.editasmedicine.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-36.92%
EV Earnings	-1.76x
EV/FCF	-1.36x
EV/Sales	5.12x
FCF yield	-47.82%
P/B ratio	66.94x
P/S ratio	7.63x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-230.09%
EBITDA Margin	-220.16%
Gross margin	-109.24%
Gross Profit	$-32M
Net Income	$-82.5M
Net Income Growth Quarters	4%
Net Income Growth Years	1%
Pretax Margin	-281.59%
Profit Margin	-281.59%
Profit Per Employee	$-948,407
ROA	-26.95
Roa5y	-24.58
ROCE	-81.26
ROE	-326.1
Roe5y	-85.66
ROIC	-96.55

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	130.3%
Cagr3y	-31.84%
Cagr5y	-38.05%
EPS Growth Quarters	4
EPS Growth Years	1
Revenue Growth	7.97x
Revenue Growth Q	-39.22x
Revenue Growth Years	1x
Revenue Growth3 Y	19.29x
Revenue Growth5 Y	-15.82x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.19
Assets	$113.1M
Cash	$93.6M
Current Assets	$93.9M
Current Liabilities	$29.2M
Debt	$13.1M
Debt Equity	$3.92
Debt FCF	$-0.12
Equity	$3.3M
Interest Coverage	-17.71
Liabilities	$109.8M
Long Term Assets	$19.2M
Long Term Liabilities	$80.6M
Net Cash	$80.5M
Net Cash By Market Cap	$36.04
Net Cash Growth	-43.98%
Net Debt Equity	$-24.13
Tangible Book Value	$3.3M
Tangible Book Value Per Share	$0.03
WACC	16.39

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.22
Net Working Capital	$-21.7M
Quick ratio	3.17
Working Capital	$66.9M
Working Capital Turnover	$0.24

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-11.9%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	130.17%
200-day SMA	2.66
3Y total return	-68.34%
50-day SMA	2.7
50-day SMA vs 200-day SMA	50over200
5Y total return	-90.87%
All Time High	98.2
All Time High Change	-96.75%
All Time High Date	2021-01-08
All Time Low	0.92
All Time Low Change	246.46%
All Time Low Date	2025-04-07
ATR	0.24
Beta	2.14
Ch YTD	54.75
High	3.19
High52	4.53
High52 Date	2025-10-08
High52ch	-29.63%
Low	3.04
Low52	1.29
Low52 Date	2025-05-08
Low52ch	147.12%
Ma50ch	17.94%
Price vs 200-day SMA	19.93%
RSI	57.3
RSI Monthly	45.09
RSI Weekly	58.79
Sharpe ratio	1.14x
Sortino ratio	2.02
Total Return	-11.9%
Tr YTD	54.75
Tr1m	16.67%
Tr1w	9.17%
Tr3m	75.15%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-67.4M
Operating margin	-230.1

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	97,636,421%
Shares Insiders	0.28%
Shares Institutions	51.86%
Shares Qo Q	0.64%
Shares Yo Y	11.9%
Short Ratio	6.79

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-113.8M
Average Volume	18,635.75x
Bv Per Share	0.03
CAPEX	$-443,023
Ch1m	16.68
Ch1w	9.17
Ch1y	130.2
Ch3m	75.15
Ch3y	-68.34
Ch5y	-90.87
Ch6m	31.78
Change	3.84%
Change From Open	3.84
Close	3.07
Days Gap	0
Depreciation Amortization	2,818,894.3
Dollar Volume	49,519.3
Earnings Date	2026-05-11
EBIT	$-67.4M
EBITDA	$-64.5M
EPS	$-0.89
F Score	3
FCF	$-106.8M
FCF EV Yield	-73.48x
Financing CF	31,736,381
Fiscal Year End	December
Founded	2,013
Investing CF	62,360,280
Is Primary Listing	0
Last Earnings Date	2025-10-31
Last Report Date	2026-03-31
Ma150	2.61
Ma150ch	22.04%
Ma20	3.17
Ma20ch	0.69%
Net CF	-12,306,964
Next Earnings Date	2026-05-11
Open	3.07
Position In Range	100
Ppne	13,420,372.1
Price Date	2026-05-08
Ptbv Ratio	66.94
Relative Volume	0.87x
Revenue	29,302,402x
SBC By Revenue	23.58x
Share Based Comp	6,908,894
Tr6m	31.78%
Volume	15,534
Z Score	-15.61

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0IFK pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0IFK stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0IFK?

Insider, institutional, and short-interest positioning.

Institutional ownership

+51.9%

Share of float held by funds and institutions

Insider ownership

+0.3%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0IFK momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

57.3

Neutral momentum band

Price vs 200-day MA

+19.9%

50/200-day relationship not available

Beta (5Y)

2.14

More volatile than the market

Sharpe ratio

1.14

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0IFK

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0IFK stock rating?

lon/0IFK is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0IFK analysis?

The full report lives at /stocks/lon/0IFK/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0IFK?

The latest report frames lon/0IFK around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0IFK page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.